Panel discussion, 22nd September: Improving patient outcomes - is digital the solution?

How can we tackle the need to improve patient outcomes? Does digital have the answer?

A panel discussion addressing these questions will take place at the Next Pharma Summit on 22nd September 2021 at 13.20 GMT. Chaired by Dr Tim Ringrose, Tim will be joined by thought leaders Trudie Lobban (CEO of STARS, AF Association and Arrhythmia Alliance), Richard Condon (Digital Innovation Lab Lead, Bayer) and John Gordon (Business Unit Head, Pfizer).

Register for free at nextpharmasummit.com/nextnormal

An introduction to the panel discussion:

Improving patient outcomes is the top motivation for most people who work in the healthcare industry. Whatever role we play within the industry, most of us wish to play our part in improving people’s health, quality of life and life expectancy.

Some great (and sometime incredible) advances in medicine have been made over the last 130 years, namely in medicines, antibiotics and vaccines that have moved our life expectancy from 46 years to 81 year.

But now we seem to have come to a critical point in the history of our healthcare services. No matter how hard our doctors and nurses work, health services around the world are at breaking point. We are living in a rapidly ageing population. The Office of National Statistics has said that by 2035, 25% of the world’s population will be over 65.  The number of older people diagnosed with four or more chronic conditions will double between 2015 and 2035.

The result is clinicians are dealing with a growing number of patients, often with multiple long term conditions and treatments, increased waiting lists and reduced consultation time.

It is inevitable that this impacts on patient outcomes.

In this discussion, we will discuss:

• Are there digital solutions that hold the key to solving the pressures of healthcare and improving patient outcomes?
• As we enter an era of digital Remote Patient Monitoring, can this help or hinder patient outcomes?
• Can the Pharma industry harness technology to offer a more personalised, patient centric health service that deliver improved patient outcoms and even preventative medicine?

Key learnings from this session will be:

• Our panelists’ thoughts on solutions that may help to improve patient outcomes
• Consideration of how the healthcare industry may leverage new technology to drive a more patient centric approach for better health outcomes including preventative medicine
• Thoughts on how the Pharma industry may best make the most of these technology solutions for the delivery of improved outcomes

Panelists include:

• John Gordon – Pfizer
• Richard Condon – Bayer
• Trudie Lobban – STARS, AF Association and Arrhythmia Alliance